atgtx.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://www.atgtx.com/sitemap_index.xml # --------------------------- # END YOAST | ||
Meta Tags
| Title | AtG - stopping cancer metabolic |
| Description | Overcoming Tumor At AtG, we develop new drugs and biomarkers to stop cancer metabolic |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 208.113.180.43 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
atgtx.com Valuation
|
US$381,937
Last updated: 2023-05-18 05:56:52
atgtx.com has Semrush global rank of 27,712,192. atgtx.com has an estimated worth of US$ 381,937, based on its estimated Ads revenue. atgtx.com receives approximately 44,070 unique visitors each day. Its web server is located in United States, with IP address 208.113.180.43. According to SiteAdvisor, atgtx.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$381,937 |
| Daily Ads Revenue | US$353 |
| Monthly Ads Revenue | US$10,577 |
| Yearly Ads Revenue | US$126,921 |
| Daily Unique Visitors | 2,938 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| atgtx.com. | A | 300 | IP: 208.113.180.43 |
| atgtx.com. | NS | 14400 | NS Record: ns3.dreamhost.com. |
| atgtx.com. | NS | 14400 | NS Record: ns2.dreamhost.com. |
| atgtx.com. | NS | 14400 | NS Record: ns1.dreamhost.com. |
| atgtx.com. | MX | 300 | MX Record: 0 mx1.mailchannels.net. |
| atgtx.com. | MX | 300 | MX Record: 0 mx2.mailchannels.net. |
| atgtx.com. | TXT | 300 | TXT Record: v=spf1 mx include:netblocks.dreamhost.com include:relay.mailchannels.net -all |
HtmlToTextCheckTime:2023-05-18 05:56:52
| Skip to the content AtG Therapeutics Menu About us The team Partners News Contact us Close Menu About us The team Partners News Contact us Overcoming Tumor Adaptation At AtG, we develop new drugs and biomarkers to prevent tumor adaptation vulnerabilities present in treatment naïve and resistant patients. Scroll Down Our mission Advance our portfolio of therapies to clinical trials and improve the lives of those affected by advanced cancer. Our approach Novel mechanism of action Innovative anti-cancer therapeutic target Drug candidate New small molecule candidates New biomarker Patient selection technology Learn more about us Interested in becoming a partner? Contact us Work with us Contact us ProCURE Cookie policy Latest news AtG Therapeutics Appoints Dr. Itziar Canamasas as New CEO to Drive Development of Cancer Metabolic Adaptation Inhibitors March 20, 2023 La Vanguardia – Una firma surgida del ICO logra fondos para el tratamiento de cáncer avanzado July 24, 2022 AtG Therapeutics |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Thu, 26 May 2022 16:59:25 GMT Server: Apache Location: https://www.atgtx.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/2 200 date: Thu, 26 May 2022 16:59:25 GMT server: Apache vary: Accept-Encoding,Cookie,User-Agent cache-control: max-age=3, must-revalidate content-length: 34518 last-modified: Tue, 17 May 2022 14:41:05 GMT cache-control: max-age=2592000 expires: Sat, 25 Jun 2022 16:59:25 GMT content-type: text/html; charset=UTF-8 |
atgtx.com Whois Information
Domain Name: ATGTX.COM Registry Domain ID: 2628889063_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.dreamhost.com Registrar URL: http://www.DreamHost.com Updated Date: 2021-07-24T08:42:20Z Creation Date: 2021-07-24T08:42:20Z Registry Expiry Date: 2022-07-24T08:42:20Z Registrar: DreamHost, LLC Registrar IANA ID: 431 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.DREAMHOST.COM Name Server: NS2.DREAMHOST.COM Name Server: NS3.DREAMHOST.COM DNSSEC: unsigned >>> Last update of whois database: 2022-05-26T17:27:05Z <<< |